Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001120
What this trial is testing

Patients With AIDS Syndrome

Who this might be right for
Sarcoma, KaposiLymphoma, Non-HodgkinHIV Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724834
What this trial is testing

CD19-B Cell Depletion in PAIS-ME/CFS Patients

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID 19 Condition (PCC or Long COVID)Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Charite University, Berlin, Germany 38
Early research (Phase 1)Study completedNCT00119873
What this trial is testing

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01707472
What this trial is testing

Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Who this might be right for
Liver FibrosisHepatitis CHIV+1 more
Gilead Sciences 18
Testing effectiveness (Phase 2)Ended earlyNCT00865566
What this trial is testing

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Not applicableStudy completedNCT04768244
What this trial is testing

Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health

Who this might be right for
Covid19
Institute of Agrochemistry and Food Technology, National Research Council 100
Testing effectiveness (Phase 2)Study completedNCT02716675
What this trial is testing

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,699
Not applicableStudy completedNCT02877199
What this trial is testing

Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy

Who this might be right for
Hepatitis C
Hospices Civils de Lyon 19
Not applicableStudy completedNCT04932967
What this trial is testing

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

Who this might be right for
Covid19Hematological Malignancy
Gruppo Italiano Malattie EMatologiche dell'Adulto 91
Testing effectiveness (Phase 2)Looking for participantsNCT05771402
What this trial is testing

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

Who this might be right for
Chronic Hepatitis bAnti-PD-1 AntibodyPeg-IFNα
The Second Affiliated Hospital of Chongqing Medical University 120
Early research (Phase 1)Study completedNCT05245292
What this trial is testing

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 28
Large-scale testing (Phase 3)Study completedNCT03999996
What this trial is testing

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Who this might be right for
Dengue Fever
Takeda 365
Not applicableStudy completedNCT05338762
What this trial is testing

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

Who this might be right for
SARS-CoV2 Infection
MiCo BioMed Co., Ltd. 218
Not applicableLooking for participantsNCT05127980
What this trial is testing

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

Who this might be right for
Epstein-Barr Virus (EBV) Infection
University Hospital, Basel, Switzerland 80
Post-approval studies (Phase 4)Study completedNCT01000324
What this trial is testing

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Who this might be right for
Hepatitis AHepatitis B
GlaxoSmithKline 44
Testing effectiveness (Phase 2)UnknownNCT05200754
What this trial is testing

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Carsten Müller-Tidow 174
Not applicableUnknownNCT05038475
What this trial is testing

Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionOlfactory Disorder+3 more
Association "Naso Sano" Onlus 100
Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Post-approval studies (Phase 4)Study completedNCT05142319
What this trial is testing

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

Who this might be right for
COVID-19
Tan Tock Seng Hospital 326
Testing effectiveness (Phase 2)WithdrawnNCT02438345
What this trial is testing

PRO 140 for Human Immunodeficiency Virus

Who this might be right for
HIV
Drexel University
Next Page